Aurenyx Pharmatech Private Limited, a active private limited company, was established on 21 February 2011 in Shirur, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U74900PN2011PTC138608. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Balvant Kakaso Nawale (Additional Director), Sachin Bhausaheb Bhalekar (Director). Past directors included Anil Patil Prabhakarrao, Bhausaheb Nana Bhalekar, Sandip Bhimaji Ghule. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 841, Hudaco Colony Shirur, Pune, Shirur, Maharashtra, 412210.
U74900PN2011PTC138608
138608
21 February 2011
₹1.00 M
₹0.10 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Aurenyx Pharmatech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Balvant Kakaso Nawale | Additional Director | 20 Aug 2020 | Current |
| Sachin Bhausaheb Bhalekar | Director | 21 Feb 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 28 Aug 2013 | Past |
| Pramod Abcsdd | Additional Director | 27 May 2020 | Past |
| Pramod Abcsdd | Additional Director | 17 Nov 2015 | Past |
| Pramod Abcsdd | Director | 05 Dec 2012 | Past |
| Pramod Abcsdd | Director | 05 Dec 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cyclone Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 44.71% increase. The company also saw a substantial fall in profitability, with a 394.44% decrease in profit. The company's net worth observed a substantial decline by a decrease of 510.39%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Aurenyx Pharmatech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Aurenyx Pharmatech has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Aurenyx Pharmatech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aurenyx Pharmatech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Aurenyx Pharmatech Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Aurenyx Pharmatech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was completed.
Progress on Balvant Kakaso Nawale was appointed as a Additional Director was appointed as a Additional Director on 20 Aug 2020 & has been associated with this company since 5 years 3 months . was documented.
Progress on Sachin Bhausaheb Bhalekar was appointed as a Director was appointed as a Director on 21 Feb 2011 & has been associated with this company since 14 years 9 months . was documented.
The activity Aurenyx Pharmatech Private Limited was registered on 21 Feb 2011 with Roc Pune & aged 14 years 9 months as per MCA records. was completed.
The CIN of Aurenyx Pharmatech Private Limited is U74900PN2011PTC138608.
Aurenyx Pharmatech Private Limited is headquartered at 841, Hudaco Colony Shirur, Pune, Shirur, Maharashtra, 412210.
Aurenyx Pharmatech Private Limited was incorporated on 21 February 2011.
The current directors of Aurenyx Pharmatech Private Limited are
The primary industry of Aurenyx Pharmatech Private Limited is Trade.
Aurenyx Pharmatech Private Limited is unlisted.
The authorized capital of Aurenyx Pharmatech Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Aurenyx Pharmatech Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX